pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
DSP-3077
Retinitis Pigmentosa (Retinitis)
Sumitomo Pharma Co Ltd
0
catalysts
Phase 2
DT-101
Major Depressive Disorder
Draig Therapeutics Ltd
0
catalysts
Phase 2
DT-168
Fuchs Endothelial Corneal Dystrophy (FECD)
Metabotropic glutamate receptor 4
$DSGN
Design Therapeutics, Inc.
0
catalysts
← prev
page 11 of 50
next →
131
Pain
89
Neurology
1
Phase 2
DX-126262
Gastric Cancer
Hangzhou DAC Biotech Co Ltd
0
catalysts
Phase 2
Decoy-20
Adenoid Cystic Carcinoma (ACC)
$INDP
Indaptus Therapeutics, Inc.
0
catalysts
Phase 2
EB-103
B-Cell Non-Hodgkin Lymphoma
$ESLA
Estrella Immunopharma, Inc.
0
catalysts
Phase 2
EBT-101
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Excision BioTherapeutics Inc
0
catalysts
Phase 2
ECC-0509
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Eccogene (Shanghai) Co Ltd
0
catalysts
Phase 2
ECC-4703
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Eccogene (Shanghai) Co Ltd
0
catalysts
Phase 2
EDV-2209
Subarachnoid Hemorrhage
Edvince AB
0
catalysts
Phase 2
EEDVD-682
Pancreatic Ductal Adenocarcinoma
EnGeneIC Ltd
0
catalysts
Phase 2
EF-001
Anaplastic Astrocytoma
Everfront Biotech Inc
0
catalysts
Phase 2
EG-007
Endometrial Cancer
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 2
EG-110A
Neurogenic Bladder Dysfunction
EG 427
0
catalysts
Phase 2
EG-501
Cognitive Impairment
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 2
EGT-101
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
0
catalysts
Phase 2
EH-301
Amyotrophic Lateral Sclerosis
Elysium Health Inc
0
catalysts
Phase 2
EIS-12656
Breast Cancer
Eisbach Bio GmbH
0
catalysts
Phase 2
ELI-002 2P
Colorectal Cancer
$ELTX
Elicio Therapeutics, Inc.
0
catalysts
Phase 2
ELU-42
Diabetic Foot Ulcers
Eluciderm Inc
0
catalysts
Phase 2
ELVN-002
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
$ELVN
Enliven Therapeutics, Inc.
0
catalysts
Phase 2
EN-374
Chronic Granulomatous Disease
Ensoma Inc
0
catalysts
Phase 2
ENB-003
Pancreatic Cancer
ENB Therapeutics LLC
0
catalysts
Phase 2
EO-2463
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
Enterome Bioscience SA
0
catalysts
Phase 2
EPI-321
Facioscapulohumeral Muscular Dystrophy (FSHD)
Epicrispr Biotechnologies Inc
0
catalysts
Phase 2
ERC-1671
Gliovac
Gliosarcoma
ERC Belgium SA
0
catalysts
Phase 2
ET-1402
Hepatocellular Carcinoma
Eureka Therapeutics Inc
0
catalysts
Phase 2
ETD-001
Cystic Fibrosis
Enterprise Therapeutics Ltd
0
catalysts
Phase 2
ETX-101
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Encoded Therapeutics Inc
0
catalysts
Phase 2
ETX-19477
Ovarian Cancer
858 Therapeutics Inc
0
catalysts
